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that leverages recent structural data, we present a model for the supramolecular
structure of the rod cell disc membrane phototransduction machinery. We first
show a comparison of multiple rhodopsin dimer interfaces in a model mem-
brane using a coarse-grained molecular dynamics simulation approach accu-
mulating more than a millisecond of simulation time. To characterize the
preferred binding interface of a pair of rhodopsins, we determined the poten-
tials of mean force as a function of the distance between two membrane-
embedded receptors. The interfaces probed include helix 4 (H4), H4/H5, H5,
H6 and H1/H8. The results show that the most stable rhodopsin dimer exists
in a tail-to-tail conformation, with the interface comprising transmembrane
H1 and H2 at the extracellular side and amphipathic H8 at the cytoplasmic
one. The existence of the H1/H8 dimer was unambiguously corroborated by
crosslinking experiments in which we identified CYS316 in H8 as the site of
a chemical crosslink between two rhodopsins in native ROS disc membrane us-
ing proteolysis, CNBr cleavage, and high-resolution liquid-chromatography
mass-spectroscopy (LC/MS). We then show how secondary interaction sur-
faces appear to stabilize extended ‘‘lubricated’’ rows of these dimers as seen
earlier in atomic force microscopy studies. The synthesis of the new rhodopsin
dimer orientation with the structures of the R*/Gt complex in two different ori-
entations and 3-D densities of the complex obtained earlier by electron-
microscopy argues for novel alternatives for the supramolecular organization
of ROS membrane. The model we propose suggests the possibility for an effi-
cient one-dimensional mechanism for Gt to search for active receptor (R*) even
under low light conditions.
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The recent crystal structure1 of the b2 adrenergic receptor-Gs protein complex
(b2AR-Gs) marks an important milestone in a two decades long race to deci-
pher one of the most important and widely utilized signal-transduction mech-
anisms in biology. However, it is unclear how the relatively drastic and
unexpected conformational changes evolve from the initial encounter complex.
The number of compositional and conformational microstates that evolve along
the reaction pathway from the initial encounter of agonist-activated receptor
with the GDP-bound heterotrimeric G-protein to the nucleotide-free agonist-re-
ceptor-G protein ternary complex is potentially very large.2 Identification of
these pathways is out of reach for crystallographic experiments, and we follow
a complementary approach with large-scale molecular dynamics (MD) simula-
tions of membrane-embedded, fully solvated metarhodopsin II alone and in
complex with its cognate G-protein, transducin, in GDP-bound form. Here,
we compare and contrast the relaxation of two different encounter complexes,
one with an orientation similar to b2AR-Gs, and the other 120
 rotated. Inter-
estingly, the two different pre-aligned encounter complexes yield induced-fit
complexes that share a signature set of conformational changes involving
highly conserved residues in the three allosterically coupled domains, the
agonist-binding, G-protein-binding, and nucleotide-binding sites. How are
these canonical and non-canonical binding modes possible for such a high fidel-
ity signal-transduction system? Is it possible that Nature utilizes multiple, en-
ergetically similar states to relay the information encoded in the relatively
small free energy of agonist binding across about ten nanometers distance to
the nucleotide-binding pocket? It is tempting to speculate about the role of
these energetically near-equivalent microstates when discussing the dominat-
ing entropic contribution to the binding free energy of agonists at the b adren-
ergic receptors.
1Rasmussen, et al. (2011) Nature 477, 549.
2Huber and Sakmar (2011) Trends. Pharmacol. Sci. 32, 410.
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Within the rod cell of the retina, absorption of light by the G-protein coupled
receptor rhodopsin leads to the formation of the agonist all-trans-retinal di-
rectly within the ligand binding pocket of opsin and the eventual formation
of the active species Metarhodopsin II (Meta II). Meta II signaling is termi-
nated by phosphorylation and binding of arrestin, and Meta II eventually de-
cays to opsin and free retinal via the spontaneous hydrolysis of the covalent
retinal Schiff-base linkage. It has been known for some time that arrestin binds
photo-decayed phosphorylated rhodopsin, as well as phosphorylated opsin(OpsP) supplied with exogenous all-trans-retinal. We find that all-trans-
retinal can enter OpsP and form a Schiff-base in an arrestin-dependent fashion,
thus forming a Meta II-like species. The agonist, arrestin, and the receptor exist
in coupled equilibria, such that arrestin stabilizes an activated form of OpsP
that allows all-trans-retinal to enter the binding pocket. This is the first direct
observation of the reversible formation of a Meta II-like species from opsin
and all-trans-retinal in the native membrane environment. As we recently re-
ported for arrestin binding to Meta II (Sommer ME, Hofmann KP and Heck
M (2011) JBC 286: 7359-69), we now find that one arrestin binds for every
two OpsP receptors in the presence of excess all-trans-retinal. Furthermore, ar-
restin can induce the formation of the Meta II-like species in only half of the
OpsP population. Likewise, regeneration of half the arrestin-bound OpsP pop-
ulation with 11-cis-retinal is blocked, supposedly because the binding pocket is
already occupied. Regeneration of the remaining half of OpsP requires release
of arrestin via the removal of all-trans-retinal by retinal dehydrogenase. To-
gether these results suggest that arrestin serves to both terminate Meta II sig-
naling and to regulate retinoid flow through opsin.
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Extracellular signals prompt G protein-coupled receptors (GPCRs) to adopt an
active conformation (R*) and to catalyze GDP/GTP exchange in the a-subunit
of intracellular G proteins (Gabg). Kinetic analysis of transducin (Gtabg) ac-
tivation has shown that an intermediary R*$Gtabg$GDP complex is formed
which precedes GDP release and formation of the nucleotide-free R*$G protein
complex. Based on this reaction sequence we explore the dynamic interface be-
tween the proteins during formation of these complexes. We start from the R*
conformation stabilized by a Gta C-terminal peptide (GaCT) obtained from
crystal structures of the GPCR opsin. Molecular modeling allows reconstruc-
tion of the fully elongated C-terminal a-helix of Gta (a5) and shows how a5
can be docked to the open binding site of R*. Two modes of interaction are
found. One of them - termed stable or S-interaction - matches the position of
the GaCT peptide in the crystal structure and reproduces the hydrogen bridge
networks between the C-terminal reverse turn of GaCT and conserved E(D)RY
and NPxxY(x)5,6F regions of the GPCR. The alternative fit - termed intermedi-
ary or I-interaction - is distinguished by a tilt and significant clockwise rotation
of a5 relative to the S-interaction. It shows different a5 contacts with the
NPxxY(x)5,6F region and the second cytoplasmic loop of R*. From the two
a5 interactions, we derive a ‘helix switch’ mechanism for the transition of
R*$Gtabg$GDP to the nucleotide-free R*$G protein complex. It illustrates
how a5 acts as a transmission rod to propagate the conformational change
from the receptor-G protein interface to the nucleotide binding site. The results
are discussed in light of the recent structure of the b2 adrenergic receptor-Gs
protein complex. A detailed mechanism of complex formation and GDP release
is derived.
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Channelrhodopsins are sensory photoreceptors that mediate phototaxis in
green algae (1, 2). Their function as ion channels renders them useful tools
in the field of neuroscience. Due to the prolonged lifetime and light-
sensitivity of the conducting state, mutantants of cysteine 128 are especially
important. They can be switched on and off by light, and are therefore called
step-function rhodopsins (3). Recent photocycle models have been proposed
on the basis of visual and vibrational spectroscopy (4, 5), however, details
of the photoreactions are still widely unknown. Here we present spectroscop-
ical data on the slow cycling mutant C128T, with 200 fold extended lifetime of
the conducting state. During the photocycle, a fraction of the proteins branches
off into a sideway consisting of blue-shifted species which accumulate during
prolonged illumination and play an important role in dark state regeneration
(5). We will show that - depending on the illumination conditions - several
structurally different dark states are regenerated. However, although such large
structural alterations occur during the photocycle, they are not necessarily con-
nected with on- and off-switching of the channel. A new model that connects
chromophore isomerization and structural alterations of the protein will be
discussed.
(1) Nagel, G. et al. (2002) Science 296, 2395-8.
(2) Nagel, G. et al. (2003) Proceedings of the National Academy of Sciences of
the United States of America 100, 13940-5.
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(4) Radu, I. et al. (2009) Journal of the American Chemical Society 131,
7313-9.
(5) Stehfest, K. et al. (2010) Journal of molecular biology 398, 690-702.
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G-protein coupled receptors (GPCRs) are the largest family of membrane sig-
naling proteins. They respond to a wide-array of stimuli and contain a seven
transmembrane domain that couples to heterotrimeric G-proteins. These path-
ways play roles in controlling second messenger levels and regulating other
signaling proteins, such as ion channels and kinases. Due to their importance
in many diseases, GPCRs are the most explored drug targets in biology. De-
spite this, the specific biochemical, physiological, and behavioral roles of
many GPCRs are not well-understood and make this field ripe for the applica-
tion of new tools for high-precision probing. We have developed an approach
to elucidate the function of a GPCR by chemically re-engineering it to be sen-
sitive to light. The class C glutamate-gated GPCR, mGluR2, which couples to
the Gi/o pathway, was derivatized with photoswitchable ligands to generate
both light-agonized (LimGluR2) and light-antagonized (‘‘LimGluR2-block’’)
receptors. The bistable, azobenzene photoswitch enables activation by a light
pulse to be sustained for long periods in the dark before being switched off by
a longer wavelength light pulse. LimGluR2 deactivates quickly and supports
multiple reproducible rounds of on/off switching with superior fidelity and
speed compared to Rhodopsin. We have extended optical control to a variety
of mGluRs with distinct G-protein coupling profiles. These designed receptors
provide excellent tools for the dissection of the specific roles of different
mGluRs in physiological functions, such as induction of synaptic plasticity,
with high spatiotemporal precision. Furthermore, the high level of control af-
forded by tethered agonists allows for the probing of coupling of ligand-
binding to receptor activation with single-subunit control. Along with
single-molecule fluorescence experiments, we have used optical control via
LimGluRs to probe the mechanisms of assembly and cooperative activation
in the class C GPCRs.
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Prostaglandin E2 (PGE2) favors cancer progression by promoting angiogenesis
and metastasis, and by influencing the immune response, thus being a key tu-
morigenic factor. The specificity and diversity of PGE2 effects can be ex-
plained by cells expressing a characteristic pattern of different EP receptors
with distinctive signaling mechanisms. PGE2 signaling through both EP2
and EP4 receptors coupled to the G-protein Gas is known to stimulate
cAMP production. Interestingly, although details of the down-stream signaling
pathways remain unknown, increasing evidence suggests that EP4 also couples
to Gai, which is known to inhibit cAMP production, thus triggering a natural
inhibitory pathway. We aim to unravel the dynamics and molecular mecha-
nisms of the cross-talk of EP2 and EP4 receptors via the inhibitory Gai and
the stimulatory Gas signaling axis at the molecular level. FRAP and FLIM
studies confirmed that only EP4 signals via Gai and showed that although
the intitiation of PGE2-induced Gas and Gai signaling occurs simultaneously,
Gas signals longer than Gai. Single-particle tracking of q-dot labeled receptors
revealed that EP4 slows down upon PGE2 stimulation whereas EP2 only de-
creases mobility when EP4 is present, suggesting cross talk. Furthermore, using
a cAMP FRET-sensor we were able to investigate the extent of cAMP produc-
tion using EP2 and EP4 specific agonist/antagonist and showed that EP4 signal-
ing caused a transient cAMP response. We propose a model where EP4 allows
for the fine-tuning of the cell’s response to PGE2, providing a threshold for
a cell to respond to PGE2, whereas EP2 continuously signals to high levels
of PGE2. We believe that targeting PGE2 signaling and control the outcomeof the cell’s response to PGE2 will provide new tools for the development of
alternative therapeutic approaches to cancer treatment.
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The lower liability of atypical antipsychotics to produce side-effects corre-
lates with their faster rates of dissociation from the dopamine D2 receptor.
Recent studies indicate that the novel D2 ligands, ACR16 and OSU6162,
act as antagonists with similarly high dissociation rates. However, those
studies measured dissociation of radiolabeled ligand from membrane prepa-
rations or used modified G proteins to study calcium release. We examined
relative antagonist dissociation rates in living cells, using a time-resolved as-
say based on activation of G protein-coupled potassium channels (GIRK) by
native G proteins. GIRK responses to dopamine receptor activation were
studied using two-electrode voltage clamp in Xenopus oocytes expressing
D2 receptors and GIRK. First, dopamine was applied, resulting in a ‘‘base-
line’’ response. Next, antagonist was washed in, in the continued presence
of dopamine. After attaining steady-state response inhibition, antagonist
was washed out, still in the presence of dopamine. Response recovery
was recorded over six minutes, and the time-course and relative amplitude
of recovery were taken as measures of antagonist dissociation. Significant
differences in response recovery T1/2 and recovery amplitudes were ob-
served between the different D2 receptor antagonists: In experiments with
haloperidol, risperidone, and aripiprazole, virtually no response recovery
was observed. With clozapine and quetiapine, similar recovery amplitudes
and recovery time courses were observed (T1/2 ~ 40 s). ACR16 and
OSU6162 behaved as antagonists, lacking detectable efficacy in the GIRK
assay. These compounds washed out with similar time courses (T1/2 ~ 8
s); significantly faster than the other antagonists. ACR16 and OSU6162 ap-
pear to dissociate faster than clozapine and quetiapine, a finding which has
not been reported earlier. Such very rapid dissociation might be relevant to
the low incidence of side effects reported from clinical trials with these
compounds.
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G protein-coupled receptors (GPCRs) are proteins that span the cell mem-
brane seven times. They are stimulated by extracellular agonists and acti-
vate heterotrimeric G proteins to elicit intracellular responses. Recent
evidence suggests that GPCRs are voltage-sensitive: They exhibit gating
currents similar to ion channels and respond to depolarization of the plasma
membrane with changes in agonist affinity. We used a FRET-based biosen-
sor of the a2A adrenergic receptor to analyze voltage dependence of recep-
tor activation in HEK 293 cells by means of voltage-clamp recording. The
biosensor was stimulated either with the partial agonist clonidine or with
the full agonist norepinephrine (NE) and receptor activation was measured
as decrease in FRET ratio. Receptor stimulation by NE was reduced by
membrane depolarization and enhanced by hyperpolarization. This effect
was present in wilde-type receptors and transduced to the level of G protein
activation, which we determined in a FRET assay that directly detects Gai
protein activation. Depolarization-mediated inhibition of NE activated re-
ceptors was strong at low concentrations (500 nM: 60 % inhibition) but al-
most undetectable at saturating agonist concentrations (100 mM: 9 %
inhibition). Both agonist-induced and hyperpolarization-induced receptor ac-
tivation exhibited a similar monoexponential time course. For both activa-
tion modes, speed of activation was primarily dependent on agonist
concentration, indicating that depolarization lowers the apparent affinity
of the NE receptor interaction and thus causes receptor deactivation by
means of NE release. Application of clonidine (1 mM, VM=-90 mV) re-
sulted in a FRET response that was inhibited by 40 % at þ60 mV. In con-
trast to NE, strong receptor-inhibition at þ60 mV was present even at
super-saturating concentrations of clonidine (100 mM). Therefore we con-
clude that negative membrane potentials promote active conformations of
the a2A adrenergic receptor, increase affinity of full agonists and enhance
G protein signaling.
